AKT1 and cancer: Hyperactivation of the Akt/mTOR/c-Myc signaling pathway in cancer cells increases the expression of GLUT4, which in turn augments the ability of multidrug resistant cells to rapidly transport and consume glucose through glycolysis (Zhang et al., 2017).